Table 2. Adverse events.
| SOF + DCV (N = 12) | SOF + DCV + RBV (N = 17) | Total (N = 29) | |
|---|---|---|---|
| Any adverse event | |||
| No. of events | 35 | 106 | 141 |
| No. of patients | 10 | 16 | 26 (90) |
| with event | |||
| Adverse events occurring in > 10% of patients | |||
| Agitation | 1 | 4 | 5 (17) |
| Anemia | 0 | 3 | 3 (10) |
| Anorexia | 1 | 2 | 3 (10) |
| Arthralgia | 2 | 1 | 3 (10) |
| Back pain | 1 | 2 | 3 (10) |
| Concentration | 3 | 1 | 4 (14) |
| impairment | |||
| Dizziness | 2 | 4 | 6 (21) |
| Dry mouth | 1 | 2 | 3 (10) |
| Dry skin | 1 | 3 | 4 (14) |
| Dyspnea | 0 | 3 | 3 (10) |
| Fatigue | 4 | 8 | 12 (41) |
| Flu like symptoms | 0 | 4 | 4 (14) |
| Headache | 3 | 8 | 11 (40) |
| Insomnia | 2 | 7 | 9(31) |
| Myalgia | 2 | 2 | 4 (14) |
| Nausea | 1 | 5 | 6 (21) |
| Skin rash | 1 | 4 | 5 (17) |
| Upper respiratory | 2 | 1 | 3 (10) |
| infection | |||
Data shown as number (%).